Skip to main content

Stress e malattie dermatologiche

  • Chapter
Stress e disturbi da somatizzazione
  • 1124 Accesses

Riassunto

Le malattie della pelle sono frequenti. Per la sola psoriasi, ad esempio, è stata stimata una prevalenza del 2–3% nella popolazione generale di vari Paesi europei [1]. Sono patologie che possono presentarsi con vari sintomi e segni come dolore, prurito, bruciore, formazione di bolle, alterazioni della pigmentazione o del colore della pelle, ispessimento della cute, perdita di peli, capelli o sopracciglia. Le lesioni cutanee possono essere visibili e compromettere l’aspetto della persona o comportare vere e proprie deturpazioni fisiche. Si comprende dunque come tali patologie possano comportare un forte carico di sofferenza e disabilità e influenzare seriamente la vita delle persone affette. Alcuni pazienti riferiscono esperienze di stigmatizzazione

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Schafer T (2006) Epidemiology of psoriasis. Review and the German perspective. Dermatology 212:327–337

    Article  PubMed  Google Scholar 

  2. Kent G (2005) Stigmatisation and skin conditions. In: Walker C, Papadopoulos L (eds) Psychodermatology. Cambridge University Press, Cambridge

    Google Scholar 

  3. Verhoeven EW, Kraaimaat FW, van de Kerkhof PC et al (2007) Psychosocial well-being of patients with skindiseases in general practice. J Eur Acad Dermatol Venereol 21:662–668

    PubMed  Google Scholar 

  4. Koblentzer CS (1983) Psychosomatic concepts in dermatology. Arch Dermatol 119:501–512

    Article  Google Scholar 

  5. Picardi A, Abeni D, Melchi CF et al (2000) Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 143:983–991

    Article  PubMed  Google Scholar 

  6. Picardi A, Pasquini P, Abeni D et al (2005) Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom 74:315–322

    Article  PubMed  Google Scholar 

  7. Fava GA, Freyberger H, Bech P et al (1995) Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 63:1–8

    Article  PubMed  Google Scholar 

  8. Picardi A, Porcelli P, Pasquini P et al (2006) Integration of multiple criteria for psychosomatic assessment of dermatological patients. Psychosomatics 47:122–128

    Article  PubMed  Google Scholar 

  9. Aktan S, Ozmen E, Sanli B (1998) Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 197:230–234

    Article  PubMed  Google Scholar 

  10. Attah Johnson FY, Mostaghimi H (1995) Co-morbidity between dermatologic diseases and psychiatric disorders in Papua New Guinea. Int J Dermatol 34:244–248

    Article  PubMed  Google Scholar 

  11. Cohen AD, Ofek-Shlomai A, Vardy DA et al (2006) Depression in dermatological patients identified by the Mini International Neuropsychiatric Interview Questionnaire. J Am Acad Dermatol 54:94–99

    Article  PubMed  Google Scholar 

  12. Dehen L, Taieb C, Myon E, Dubertret L (2006) Dermatosis and depressive symptoms. Ann Dermatol Venereol 133:125–129

    Article  PubMed  Google Scholar 

  13. Hughes JE, Barraclough BM, Hamblin LG, White JE (1983) Psychiatric symptoms in dermatology patients. Br J Psychiatry 143:51–54

    Article  PubMed  Google Scholar 

  14. Niemeier V, Harth W, Kupfer J et al (2002) Prevalence of psychosomatic disorders in derma8 Stress e malattie dermatologiche 123 tologic patients. Experiences in dermatology clinics with a liaison therapy model. Hautarzt 53:471–477

    Article  PubMed  Google Scholar 

  15. Wessely SC, Lewis GH (1989) The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 155:686–691

    PubMed  Google Scholar 

  16. Aktan S, Ozmen E, Sanli B (2000) Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 39:354–357

    Article  PubMed  Google Scholar 

  17. Colón EA, Popkin MK, Callies AL et al (1991) Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 32:245–251

    Article  PubMed  Google Scholar 

  18. Esposito M, Saraceno R, Giunta A et al (2006) An Italian study on psoriasis and depression. Dermatology 212:123–127

    Article  PubMed  Google Scholar 

  19. Finzi A, Colombo D, Caputo A et al; PSYCHAE Study Group (2007) Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol 21:1161–1169

    Google Scholar 

  20. Gupta MA, Gupta AK (1998) Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 139:846–850

    Article  PubMed  Google Scholar 

  21. Kent G, Al’Abadie M (1996) Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 35:895–898

    Article  PubMed  Google Scholar 

  22. Koo JY, Shellow WV, Hallman CP, Edwards JE (1994) Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 33:849–850

    Article  PubMed  Google Scholar 

  23. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R (2001) Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol 28, 424–432.

    PubMed  Google Scholar 

  24. Mozzetta A, Antinone V, Alfani S et al (2008) Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol 22:336–340

    Article  PubMed  Google Scholar 

  25. Schneider G, Driesch G, Heuft G et al (2006) Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Experim Dermatol 31:762–767

    Article  Google Scholar 

  26. Sheehan-Dare RA, Henderson MJ, Cotterill JA (1990) Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 123:769–774

    Article  PubMed  Google Scholar 

  27. Wolkenstein P, Zeller J, Revuz J et al (2003) Visibility of neurofibromatosis 1 and psychiatric morbidity. Arch Dermatol 139:103–104

    Article  PubMed  Google Scholar 

  28. Picardi A, Abeni D, Renzi C et al (2001) Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Dermato-Venereologica 81:410–414

    Article  PubMed  Google Scholar 

  29. Cotterill JA, Cunliffe WJ (1997) Suicide in dermatological patients. Br J Dermatol 137:246–250

    Article  PubMed  Google Scholar 

  30. Humphreys F, Humphreys MS (1998) Psychiatric morbidity and skin disease: what dermatologists think they see. Br J Dermatol 139:679–681

    Article  PubMed  Google Scholar 

  31. Zachariae R, Zachariae C, Ibsen HHW et al (2004) Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta DermVenereol 84:205–212

    Google Scholar 

  32. Picardi A, Mazzotti E, Pasquini P (2006) Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol 54:420–426

    Article  PubMed  Google Scholar 

  33. Khan MZ, Naeem A, Mufti KA (2001) Prevalence of mental health problems in acne patients. J Ayub Med Coll Abbottabad 13:7–8

    PubMed  Google Scholar 

  34. Purvis D, Robinson E, Merry S, Watson P (2006) Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paed Child Health 42:793–796

    Article  Google Scholar 

  35. Halvorsen JA, Stern RS, Dalgard F et al (2011) Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: A population-based study. J Invest Dermatol 131:363–370

    Article  PubMed  Google Scholar 

  36. Kimata H (2006) Prevalence of suicidal ideation in patients with atopic dermatitis. Suicide Life Threat Behav 36:120–124

    Article  PubMed  Google Scholar 

  37. Dieris-Hirche J, Gieler U, Kupfer JP, Milch WE (2009) Suizidgedanken, Angst und Depression bei erwachsenen Neurodermitikern. Hautarzt 60:641–646

    Article  PubMed  Google Scholar 

  38. Sampogna F, Picardi A, Chren MM et al (2004) Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 66:620–624

    Article  PubMed  Google Scholar 

  39. Gupta MA, Gupta AK, Schork NJ, Ellis CN (1994) Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 56:36–40

    PubMed  Google Scholar 

  40. Reich A, Szepietowski JC, Wisnicka B, Pacan P (2003) Does stress influence itching in psoriatic patients? Dermatol Psychosom 4:151–155

    Article  Google Scholar 

  41. Yosipovitch G, Ansari N, Goon A et al (2002) Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 147:32–36

    Article  PubMed  Google Scholar 

  42. Renzi C, Picardi A, Abeni D et al (2002) Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 138:337–342

    Article  PubMed  Google Scholar 

  43. Ginsburg IH, Link BG (1989) Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 20:53–63

    Article  PubMed  Google Scholar 

  44. Richards HL, Fortune DG, Griffiths CE, Main CJ (2001) The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 50:11–15

    Article  PubMed  Google Scholar 

  45. Schmid-Ott G, Kunsebeck HW, Jager B et al (2005) Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 85: 27–32

    Article  PubMed  Google Scholar 

  46. Wittkowski A, Richards HL, Griffiths CE, Main CJ (2004) The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res 57:195–200

    Article  PubMed  Google Scholar 

  47. Fortune DG, Richards HL, Griffiths CE, Main CJ (2002) Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 41: 157–174

    Article  PubMed  Google Scholar 

  48. Gupta MA, Gupta AK (1995) The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 75:240–243

    PubMed  Google Scholar 

  49. Schmitt J, Ford DE (2007) Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis — a structural equations modeling approach. Gen Hosp Psychiatry 29:134–140

    Article  PubMed  Google Scholar 

  50. Picardi A, Abeni D, Renzi C et al (2003) Treatment outcome and incidence of psychiatric disorders in dermatological outpatients. J Eur Acad Dermatol Venereol 17:155–159

    Article  PubMed  Google Scholar 

  51. Sampogna F, Tabolli S, Abeni D (2007) The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol 157:508–513

    Article  PubMed  Google Scholar 

  52. Gaston L, Lassonde M, Bernier-Buzzanga J et al (1987) Psoriasis and stress: a prospective study. J Am Acad Dermatol 17:82–86

    Article  PubMed  Google Scholar 

  53. King RM, Wilson GV (1991) Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 35:697–706

    Article  PubMed  Google Scholar 

  54. Chiu A, Chon SY, Kimball AB (2003) The response of skin disease to stress: Changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 139:897–900

    Article  PubMed  Google Scholar 

  55. Picardi A, Abeni D (2001) Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 70:118–136

    Article  PubMed  Google Scholar 

  56. Fava GA, Perini GI, Santonastaso P, Veller Fornasa C (1980) Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 53:277–282

    Article  PubMed  Google Scholar 

  57. Lyketsos GC, Stratigos GC, Tawil G et al (1985) Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia. Psychother Psychosom 44:122–131

    Article  PubMed  Google Scholar 

  58. Naldi L., Chatenoud L., Linder D. et al (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 125:61–67

    Article  PubMed  Google Scholar 

  59. Manolache L, Petrescu-Seceleanu D, Benea V (2010) Life events involvement in psoriasis onset/ recurrence. Int J Dermatol 49:636–641

    Article  PubMed  Google Scholar 

  60. Díaz-Atienza F, Gurpegui M (2011) Environmental stress but not subjective distress in children or adolescents with alopecia areata. J Psychosom Res 71:102–107

    Article  PubMed  Google Scholar 

  61. Manolache L, Benea V (2007) Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 21:921–928

    Article  PubMed  Google Scholar 

  62. Perini GI, Veller Fornasa C, Cipriani R et al (1984) Life events and alopecia areata. Psychother Psychosom 41:48–52

    Article  PubMed  Google Scholar 

  63. Papadopoulos L, Bor R, Legg C, Hawk JL (1998) Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol 23:243–248

    Article  PubMed  Google Scholar 

  64. Manolache L, Seceleanu-Petrescu D, Benea V (2008) Lichen planus patients and stressful events. J Eur Acad Dermatol Venereol 22:437–441

    Article  PubMed  Google Scholar 

  65. Payne RA, Rowland Payne CM, Marks R (1985) Stress does not worsen psoriasis? A controlled study of 32 patients. Clin Exp Dermatol 10:239–245

    Article  PubMed  Google Scholar 

  66. Russiello F, Arciero G, Decaminada F et al (1995) Stress, attachment and skin disease: a casecontrol study. J Eur Acad Dermatol Venereol 5:234–239

    Article  Google Scholar 

  67. Picardi A, Pasquini P, Cattaruzza MS et al (2003) Stressful life events, social support, attachment security, and alexythimia in vitiligo: a case-control study. Psychother Psychosom 72:150–158

    Article  PubMed  Google Scholar 

  68. Picardi A, Pasquini P, Cattaruzza MS et al (2003) Psychosomatic factors in first-onset alopecia areata. Psychosomatics 44:374–381

    Article  PubMed  Google Scholar 

  69. Picardi A, Mazzotti E, Gaetano P et al (2005) Stress, social support, emotion regulation and exacerbation of diffuse plaque psoriasis. Psychosomatics 46:556–564

    Article  PubMed  Google Scholar 

  70. Jankovi S, Raznatovi M, Marinkovi J et al (2009) Relevance of psychosomatic factors in psoriasis: a case-control study. Acta Derm Venereol 89:364–368

    Article  Google Scholar 

  71. Yazici AC, Basterzi A, Acar ST et al (2006) Alopecia areata and alexithymia. Turk Psikiyatri Dergisi 17:101–106

    Google Scholar 

  72. Willemsen R, Haentjens P, Roseeuw D, Vanderlinden J (2009) Alexithymia in patients with alopecia areata: educational background much more important than traumatic events. J Eur Acad Dermatol Venereol 23:1141–1146

    Article  PubMed  Google Scholar 

  73. Consoli SM, Rolhion S, Martin C et al (2006) Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology 212:128–136

    Article  PubMed  Google Scholar 

  74. Evers AWM, Lu Y, Duller P et al (2005) Common burden of chronic skin diseases? Contributors to psychologycal distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 152:1275–1281

    Article  PubMed  Google Scholar 

  75. Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer, New York

    Google Scholar 

  76. Guidano VF (1991) The self in process. Guilford Press, New York (Trad. it. Il sé nel suo divenire. Bollati Boringhieri, Torino, 1992)

    Google Scholar 

  77. Biondi M, Picardi A (1999) Psychological stress and neuroendocrine function in humans: the last two decades of research. Psychother Psychosom 68:114–150

    Article  PubMed  Google Scholar 

  78. Collins NL, Feeney BC (2000) A safe haven: an attachment theory perspective on support seeking and caregiving in intimate relationships. J Pers Soc Psychol 78:1053–1073

    Article  PubMed  Google Scholar 

  79. Crittenden PM (2002) Attachment, information processing, and psychiatric disorder. World Journal of Psychiatry 1:72–75

    Google Scholar 

  80. Tausk FA, Nousari H (2001) Stress and the skin. Arch Dermatol 137:78–82

    PubMed  Google Scholar 

  81. Panconesi E, Hautmann G (1996) Psychophysiology of stress in dermatology. The psychobiologic pattern of psychosomatics. Dermatol Clin 14:399–421

    Article  PubMed  Google Scholar 

  82. Kiecolt-Glaser JK, Marucha PT, Malarkey WB et al (1995) Slowing of wound healing by psychological stress. Lancet 346:1194–1196

    Article  PubMed  Google Scholar 

  83. Garg A, Chren MM, Sands LP et al (2001) Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 137:53–59

    PubMed  Google Scholar 

  84. Robles TF (2007) Stress, social support, and delayed skin barrier recovery. Psychosom Med 69:807–815

    Article  PubMed  Google Scholar 

  85. Gupta MA, Gupta AK, Ellis CN, Koblenzer CS (2005) Psychiatric evaluation of the dermatology patient. Dermatol Clin 23:591–599

    Article  PubMed  Google Scholar 

  86. Poot F, Sampogna F, Onnis L (2007) Basic knowledge in psychodermatology. J Eur Acad Dermatol Venereol 21:227–234

    Article  PubMed  Google Scholar 

  87. Van Moffaert M (1992) Psychodermatology: an overview. Psychother Psychosom 58:125–136

    Article  PubMed  Google Scholar 

  88. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ (1997) Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133:1433–1440

    Article  PubMed  Google Scholar 

  89. Abeni D, Picardi A, Pasquini P et al (2002) Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 204:43–49

    Article  PubMed  Google Scholar 

  90. Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210–216

    Article  PubMed  Google Scholar 

  91. Mazzotti E, Barbaranelli C, Picardi A et al (2005) Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol 85:409–413

    Article  PubMed  Google Scholar 

  92. Hautmann G, Hercogova J, Lotti T (2002) Trichotillomania. J Am Acad Dermatol 46:807–821

    Article  PubMed  Google Scholar 

  93. Koblenzer CS (2010) The current management of delusional parasitosis and dermatitis artefacta. Skin Therapy Lett 15:1–3

    PubMed  Google Scholar 

  94. Picardi A, Amerio P, Baliva G et al (2004) Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Derm Venereol 84:213–217

    Article  PubMed  Google Scholar 

  95. Richards HL, Fortune DG, Weidmann A et al (2004) Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol 151:1227–1233

    Article  PubMed  Google Scholar 

  96. Rutz W, Walinder J, Eberhard G et al (1989) An educational program on depressive disorders for general practitioners on Gotland: background and evaluation. Acta Psychiatr Scand 79:19–26

    Article  PubMed  Google Scholar 

  97. Jafferany M, Van der Stoep A, Dumitrescu A, Hornung RL (2010) The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study. Int J Dermatol 49:784–789

    PubMed  Google Scholar 

  98. Gould WM (2004) Teaching psychocutaneous medicine: time for a reappraisal. Arch Dermatol 140:282–284

    Article  PubMed  Google Scholar 

  99. Detmar SB, Muller MJ, Wever LD et al (2001) The patient-physician relationship. Patientphysician communication during outpatient palliative treatment visits: an observational study. JAMA 285:1351–1357

    Article  PubMed  Google Scholar 

  100. Levinson W, Gorawara-Bhat R, Lamb J (2000) A study of patient clues and physician responses in primary care and surgical settings. JAMA 284:1021–1027

    Article  PubMed  Google Scholar 

  101. Picardi A, Abeni D, Pasquini P (2001) Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol 15:410–417

    Article  PubMed  Google Scholar 

  102. Picardi A, Abeni D, Mazzotti E et al (2004) Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire. J Psychosom Res 57:219–223

    Article  PubMed  Google Scholar 

  103. Picardi A, Adler DA, Abeni D et al (2005) Screening for depressive disorders in patients with skin diseases: a comparison of three screeners. Acta Derm Venereol 85:414–419

    Article  PubMed  Google Scholar 

  104. Picardi A, Adler DA, Chang H et al (2011) Development and preliminary validation of the PC-SAD5, a screener-derived short depression severity measure. J Eur Acad Dermatol Venereol (Epub ahead of print)

    Google Scholar 

  105. Worrall G, Angel J, Chaulk P et al (1999) Effectiveness of an educational strategy to improve family physicians’ detection and management of depression: a randomized controlled trial. Canadian Med Assoc Journal 61:37–40

    Google Scholar 

  106. Palmer SC, Coyne JC (2003) Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J Psychosom Res 54:279–287

    Article  PubMed  Google Scholar 

  107. Gould WM, Gragg TM (1983) A dermatology-psychiatry liaison clinic. J Am Acad Dermatol 9:73–77

    Article  PubMed  Google Scholar 

  108. de Korte J, Van Onselen J, Kownacki S et al (2005) Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme. J Eur Acad Dermatol Venereol 19:35–41

    Article  PubMed  Google Scholar 

  109. Millard L (2000) Dermatological practice and psychiatry. Br J Dermatol 143:920–921

    Article  PubMed  Google Scholar 

  110. Gupta MA, Gupta AK (2003) Psychiatric and psychological co-morbidity in patients with der8 matologic disorders: epidemiology and management. Am J Clin Dermatol 4:833–842

    Article  PubMed  Google Scholar 

  111. Kepska A, Hawro T, Krupinska-Kun M, Zalewska A (2011) Somatic-type delusional disorder: a case report and comments. Acta Derm Venereol 91:193–194

    PubMed  Google Scholar 

  112. Fried RG (2002) Nonpharmacologic treatments in psychodermatology. Dermatol Clin 20:177–185

    Article  PubMed  Google Scholar 

  113. Jafferany M (2007) Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 9:203–213

    Article  PubMed  Google Scholar 

  114. Perini G, Zara M, Cipriani R et al (1994) Imipramine in alopecia areata. A double-blind, placebo-controlled study. Psychother Psychosom 61:195–198

    Article  PubMed  Google Scholar 

  115. Papadopoulos L, Bor R, Legg C (1999) Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 72:385–396

    Article  PubMed  Google Scholar 

  116. Kabat-Zinn J, Wheeler E, Light T et al (1998) Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med 60:625–632

    PubMed  Google Scholar 

  117. Paradisi A, Abeni D, Finore E et al (2010) Effect of written emotional disclosure interventions in persons with psoriasis undergoing narrow band ultraviolet B phototherapy. Eur J Dermatol 20:599–605

    PubMed  Google Scholar 

  118. Picardi A, Pasquini P (2007) Toward a biopsychosocial approach to skin diseases. Adv Psychosom Med 28:109–126

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Picardi, A. (2012). Stress e malattie dermatologiche. In: Stress e disturbi da somatizzazione. Springer, Milano. https://doi.org/10.1007/978-88-470-2080-1_8

Download citation

Publish with us

Policies and ethics